Status:
UNKNOWN
Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Sex Chromosome Abnormality
Klinefelter Syndrome
Eligibility:
All Genders
18-90 years
Brief Summary
Observational study of 160 patients with sex-chromosome abnormalities and 160 matched controls. Blood, fat, muscle, skin, buccal swaps, urine will be collected and analyzed for DNA, RNA and methylatio...
Detailed Description
Background: The most prevalent SCAs are Klinefelter syndrome (KS; 47, XXY), 47,XXX, 47,XYY and Turner syndrome (TS; 45,X) with a prevalence of 85-250, 84, 98 and 50 per 100,000 liveborn boys/girls, re...
Eligibility Criteria
Inclusion
- Participants must have the sex-chromosome abnormality
Exclusion
- \-
Key Trial Info
Start Date :
June 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT05425953
Start Date
June 13 2022
End Date
May 1 2025
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus university hospital
Aarhus, Region Midt, Denmark, 8000